Principal Financial Group
IMGN

Principal Financial Group’s Immunogen Inc IMGN Stock Holding History

Principal Financial Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,127,402
Closed -$33.4M – 2530
2023
Q4 		$33.4M Buy
1,127,402
+142,738
+14% +$2.84M 0.02% 591
2023
Q3 		$15.6M Sell
984,664
-3,222
-0.3% -$53.6K 0.01% 957
2023
Q2 		$18.6M Buy
987,886
+931,890
+1,664% +$11M 0.01% 890
2023
Q1 		$215K Buy
55,996
+2,213
+4% +$9.43K ﹤0.01% 2166
2022
Q4 		$267K Buy
53,783
+1,616
+3% +$8.76K ﹤0.01% 2135
2022
Q3 		$249K Buy
52,167
+5,284
+11% +$27.9K ﹤0.01% 2145
2022
Q2 		$211K Sell
46,883
-117,121
-71% -$509K ﹤0.01% 2288
2022
Q1 		$781K Sell
164,004
-55,337
-25% -$306K ﹤0.01% 2027
2021
Q4 		$1.63M Sell
219,341
-29,618
-12% -$184K ﹤0.01% 1891
2021
Q3 		$1.41M Sell
248,959
-4,330
-2% -$25K ﹤0.01% 1931
2021
Q2 		$1.67M Sell
253,289
-6,275
-2% -$43.8K ﹤0.01% 1950
2021
Q1 		$2.1M Buy
259,564
+18,845
+8% +$154K ﹤0.01% 1844
2020
Q4 		$1.55M Sell
240,719
-40,778
-14% -$238K ﹤0.01% 1849
2020
Q3 		$1.01M Buy
281,497
+101,198
+56% +$409K ﹤0.01% 1871
2020
Q2 		$830K Buy
180,299
+138,791
+334% +$590K ﹤0.01% 1865
2020
Q1 		$141K Buy
41,508
+3,718
+10% +$16.3K ﹤0.01% 2097
2019
Q4 		$193K Sell
37,790
-3,472
-8% -$11.8K ﹤0.01% 2150
2019
Q3 		$100K Buy
41,262
+3,823
+10% +$10.2K ﹤0.01% 2181
2019
Q2 		$82K Sell
37,439
-76,941
-67% -$182K ﹤0.01% 2192
2019
Q1 		$310K Buy
114,380
+207
+0.2% +$897 ﹤0.01% 2031
2018
Q4 		$548K Buy
114,173
+3,696
+3% +$22.4K ﹤0.01% 1896
2018
Q3 		$1.05M Buy
110,477
+7,304
+7% +$70.2K ﹤0.01% 1842
2018
Q2 		$1M Buy
103,173
+15,971
+18% +$168K ﹤0.01% 1846
2018
Q1 		$918K Buy
87,202
+10,440
+14% +$103K ﹤0.01% 1841
2017
Q4 		$492K Buy
76,762
+63,708
+488% +$393K ﹤0.01% 1963
2017
Q3 		$100K Sell
13,054
-2,047
-14% -$13.6K ﹤0.01% 2142
2017
Q2 		$107K Hold
15,101
– – ﹤0.01% 2178
2017
Q1 		$58K Hold
15,101
– – ﹤0.01% 2170
2016
Q4 		$31K Hold
15,101
– – ﹤0.01% 2217
2016
Q3 		$40K Hold
15,101
– – ﹤0.01% 2148
2016
Q2 		$47K Hold
15,101
– – ﹤0.01% 2138
2016
Q1 		$129K Buy
15,101
+138
+0.9% +$1.17K ﹤0.01% 2060
2015
Q4 		$203K Buy
14,963
+382
+3% +$4.7K ﹤0.01% 2046
2015
Q3 		$140K Buy
14,581
+1,586
+12% +$23.2K ﹤0.01% 2075
2015
Q2 		$187K Buy
+12,995
New +$143K ﹤0.01% 2052
2015
Q1 		– Sell
-15,975
Closed -$97K – 2209
2014
Q4 		$97K Sell
15,975
-1,885
-11% -$17.2K ﹤0.01% 2116
2014
Q3 		$189K Hold
17,860
– – ﹤0.01% 2044
2014
Q2 		$212K Sell
17,860
-2,597
-13% -$32.6K ﹤0.01% 2072
2014
Q1 		$305K Sell
20,457
-8,614
-30% -$136K ﹤0.01% 1983
2013
Q4 		$426K Sell
29,071
-156
-0.5% -$2.4K ﹤0.01% 1908
2013
Q3 		$497K Buy
29,227
+9,898
+51% +$174K ﹤0.01% 1852
2013
Q2 		$321K Buy
+19,329
New +$313K ﹤0.01% 1921

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Principal Financial Group's IMGN Position: Q1 2024 in Review

Principal Financial Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,127,402 shares — an estimated $33.4M sold.

Principal Financial Group first reported a position in IMGN in Q2 2013 and held it in 42 quarters. The position peaked at $33.4M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Principal Financial Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Principal Financial Group sold 1,127,402 Immunogen Inc shares in Q1 2024, an estimated $33.4M.
  • Principal Financial Group first reported a position in Immunogen Inc in Q2 2013 and held it in 42 quarters.
  • Principal Financial Group's Immunogen Inc position peaked at $33.4M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Principal Financial Group's 13F filing for Q1 2024, filed 29 Apr 2024.